NASDAQ:ISPC

iSpecimen (ISPC) Stock Forecast, Price & News

$1.25

-0.01 (-0.79%)

(As of 05/26/2023 08:47 PM ET)

Compare

Today's Range: $1.22
▼
$1.30
50-Day Range: $1.23
▼
$1.88
52-Week Range: $1.17
▼
$3.26

Volume: 39,000 shs
Average Volume: 26,040 shs
Market Capitalization: $11.29 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.63

iSpecimen MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 510.0% Upside
$7.63 Price Target
Short Interest: Healthy
0.53% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.96
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Medical Sector

171st out of 1,010 stocks

Commercial Physical Research Industry

7th out of 16 stocks

3.5

Analyst's Opinion

Consensus Rating
iSpecimen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $7.63, iSpecimen has a forecasted upside of 510.0% from its current price of $1.25.
Amount of Analyst Coverage
iSpecimen has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.53% of the float of iSpecimen has been sold short.
Short Interest Ratio / Days to Cover
iSpecimen has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in iSpecimen has recently decreased by 43.00%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
iSpecimen does not currently pay a dividend.
Dividend Growth
iSpecimen does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ISPC.

3.9

News and Social Media Coverage

News Sentiment
iSpecimen has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for iSpecimen this week, compared to 2 articles on an average week.
Search Interest
2 people have searched for ISPC on MarketBeat in the last 30 days.
MarketBeat Follows
2 people have added iSpecimen to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, iSpecimen insiders have not sold or bought any company stock.
Percentage Held by Insiders
32.70% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 11.61% of the stock of iSpecimen is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of iSpecimen is -1.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of iSpecimen is -1.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
iSpecimen has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About iSpecimen (NASDAQ:ISPC) Stock

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Stock News Headlines

May 23, 2023 | finance.yahoo.com

iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023

May 18, 2023 | msn.com

Looking Into iSpecimen's Return On Capital Employed

May 29, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

May 4, 2023 | finance.yahoo.com

iSpecimen Reports First Quarter 2023 Results

April 24, 2023 | finance.yahoo.com

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

April 20, 2023 | finance.yahoo.com

iSpecimen to Report First Quarter 2023 Results on May 4, 2023

April 19, 2023 | americanbankingnews.com

Contrasting iSpecimen (ISPC) and Its Rivals

April 18, 2023 | finance.yahoo.com

Market Might Still Lack Some Conviction On iSpecimen Inc. (NASDAQ:ISPC) Even After 33% Share Price Boost

May 29, 2023 | UNKNOWN (Ad)

This NASDAQ Stock Is The Amazon Of Medical Supply

This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now

April 18, 2023 | americanbankingnews.com

iSpecimen (ISPC) and Its Rivals Head-To-Head Analysis

April 18, 2023 | americanbankingnews.com

Contrasting iSpecimen (ISPC) & Its Peers

April 17, 2023 | americanbankingnews.com

Reviewing iSpecimen (ISPC) and The Competition

April 16, 2023 | americanbankingnews.com

Financial Analysis: iSpecimen (ISPC) versus Its Peers

April 16, 2023 | americanbankingnews.com

Contrasting iSpecimen (NASDAQ:ISPC) & bioAffinity Technologies (NASDAQ:BIAF)

April 15, 2023 | americanbankingnews.com

iSpecimen (ISPC) vs. Its Competitors Head-To-Head Comparison

April 15, 2023 | americanbankingnews.com

iSpecimen (ISPC) and Its Competitors Financial Survey

April 14, 2023 | americanbankingnews.com

iSpecimen (ISPC) vs. Its Competitors Financial Contrast

April 12, 2023 | americanbankingnews.com

Critical Review: iSpecimen (ISPC) and Its Peers

April 12, 2023 | americanbankingnews.com

Head-To-Head Review: iSpecimen (ISPC) and Its Competitors

April 11, 2023 | americanbankingnews.com

iSpecimen (ISPC) versus Its Rivals Head to Head Survey

April 11, 2023 | americanbankingnews.com

Financial Survey: iSpecimen (ISPC) and Its Peers

April 11, 2023 | americanbankingnews.com

Head-To-Head Survey: iSpecimen (ISPC) & The Competition

April 10, 2023 | americanbankingnews.com

iSpecimen (ISPC) & Its Competitors Critical Comparison

April 10, 2023 | americanbankingnews.com

Contrasting iSpecimen (ISPC) & The Competition

April 8, 2023 | americanbankingnews.com

iSpecimen (ISPC) & Its Rivals Head to Head Contrast

April 8, 2023 | americanbankingnews.com

Financial Review: iSpecimen (ISPC) vs. Its Peers

April 7, 2023 | americanbankingnews.com

Analyzing iSpecimen (ISPC) and Its Peers

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

ISPC Company Calendar

Last Earnings: 3/14/2023
Today: 5/28/2023
Next Earnings (Estimated): 8/03/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ISPC
CUSIP: N/A
CIK: 1558569
Web: ispecimen.com
Phone: 781-301-6700
Fax: N/A
Employees: 59
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $7.63
High Stock Price Forecast: $11.00
Low Stock Price Forecast: $4.25
Forecasted Upside/Downside: +510.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.16)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,250,000.00
Net Margins: -95.03%
Pretax Margin: -95.02%
Return on Equity: -47.82%
Return on Assets: -39.26%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.14
Quick Ratio: 4.14

Sales & Book Value

Annual Sales: $10.40 million
Price / Sales: 1.09
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.00 per share
Price / Book: 0.63

Miscellaneous

Outstanding Shares: 9,030,000
Free Float: 6,077,000
Market Cap: $11.29 million
Optionable: Not Optionable
Beta: 1.94

Key Executives

Ms. Tracy Wilson Curley (Age 60)
CFO, Treasurer & Interim CEO
Comp: $367k

Dr. Christopher J. Ianelli M.D. (Age 54)
Ph.D., Founder & Director
Comp: $440k

Mr. Benjamin Bielak (Age 52)
Chief Information Officer
Comp: $334k

Ms. Jill Mullan (Age 57)
Sec. & Director
Comp: $391.25k

Ms. Dawn Michelle
VP of Operations

Mr. Eric Langlois
Sr. VP of Sales & Bus. Devel.

Ms. Carly Lejnieks
VP of Marketing

Ms. Emily Hubbard
VP of Site Management & Devel.

Mr. David Wages M.D.
Ph.D., Chief Medical Officer

Key Competitors

View All Competitors

ISPC Stock - Frequently Asked Questions

Should I buy or sell iSpecimen stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iSpecimen in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ISPC shares.
View ISPC analyst ratings or view top-rated stocks.
What is iSpecimen's stock price forecast for 2023?: 1 equities research analysts have issued twelve-month price objectives for iSpecimen's stock. Their ISPC share price forecasts range from $4.25 to $11.00. On average, they predict the company's share price to reach $7.63 in the next year. This suggests a possible upside of 510.0% from the stock's current price.
View analysts price targets for ISPC or view top-rated stocks among Wall Street analysts.
How have ISPC shares performed in 2023?: iSpecimen's stock was trading at $1.3750 on January 1st, 2023. Since then, ISPC shares have decreased by 9.1% and is now trading at $1.25.
View the best growth stocks for 2023 here.
Are investors shorting iSpecimen?: iSpecimen saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 28,100 shares, a decline of 43.0% from the April 30th total of 49,300 shares. Based on an average daily volume of 30,900 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.5% of the shares of the company are short sold.
View iSpecimen's Short Interest.
When is iSpecimen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our ISPC earnings forecast.
How were iSpecimen's earnings last quarter?: iSpecimen Inc. (NASDAQ:ISPC) released its quarterly earnings results on Tuesday, March, 14th. The company reported ($0.24) earnings per share for the quarter. The business earned $2.96 million during the quarter. iSpecimen had a negative net margin of 95.03% and a negative trailing twelve-month return on equity of 47.82%.

When did iSpecimen IPO?: (ISPC) raised $20 million in an initial public offering on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.
What is iSpecimen's stock symbol?: iSpecimen trades on the NASDAQ under the ticker symbol "ISPC."
How do I buy shares of iSpecimen?: Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iSpecimen's stock price today?: One share of ISPC stock can currently be purchased for approximately $1.25.
How much money does iSpecimen make?: iSpecimen (NASDAQ:ISPC) has a market capitalization of $11.29 million and generates $10.40 million in revenue each year. The company earns $-10,250,000.00 in net income (profit) each year or ($1.16) on an earnings per share basis.
How can I contact iSpecimen?: The official website for the company is ispecimen.com. The company can be reached via phone at 781-301-6700 or via email at ispecimen@kcsa.com.

This page (NASDAQ:ISPC) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

iSpecimen (ISPC) Stock Forecast, Price & News

iSpecimen MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About iSpecimen (NASDAQ:ISPC) Stock

ISPC Stock News Headlines

ISPC Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ISPC Stock - Frequently Asked Questions

Overall MarketRank^™